Changes over time in the cardiovascular risk profile of type 2 diabetes from 2007 to 2020: A community-based study.

Williams, Brent A; Brady, Jonathan P; Voyce, Stephen; Kumar, Neela; Paprocki, Yurek; Rajpura, Jigar

Williams, Brent A; Brady, Jonathan P; Voyce, Stephen; Kumar, Neela; Paprocki, Yurek; Rajpura, Jigar.

Affiliation

Williams BA; Geisinger Health System, Danville, Pennsylvania, USA.
Brady JP; Geisinger Health System, Danville, Pennsylvania, USA.
Voyce S; Geisinger Health System, Danville, Pennsylvania, USA.
Kumar N; Janssen Pharmaceuticals, Titusville, New Jersey, USA.
Paprocki Y; Novo Nordisk, Plainsboro, New Jersey, USA.
Rajpura J; Novo Nordisk, Plainsboro, New Jersey, USA.

Diabetes Obes Metab ; 24(7): 1216-1223, 2022 07.

Article in En | MEDLINE | ID: mdl-35257457

Subject(s)

Cardiovascular Diseases; Diabetes Mellitus, Type 2; Sodium-Glucose Transporter 2 Inhibitors; Cardiovascular Diseases/epidemiology; Cardiovascular Diseases/etiology; Cardiovascular Diseases/prevention & control; Diabetes Mellitus, Type 2/complications; Diabetes Mellitus, Type 2/drug therapy; Diabetes Mellitus, Type 2/epidemiology; Glucagon-Like Peptide-1 Receptor/agonists; Glycated Hemoglobin; Heart Disease Risk Factors; Humans; Hypoglycemic Agents/therapeutic use; Lipids; Risk Factors; Sodium-Glucose Transporter 2 Inhibitors/therapeutic use

Key words

cardiovascular disease; cohort study; database research; observational study; type 2 diabetes

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cardiovascular Diseases / Diabetes Mellitus, Type 2 / Sodium-Glucose Transporter 2 Inhibitors Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Diabetes Obes Metab Journal subject: ENDOCRINOLOGIA / METABOLISMO Year: 2022 Type: Article Affiliation country: United States

Fulltext

XML

PubMed Links

Search on Google